Nossas perspectivas mais recentes sobre os produtos biofármacos

As indústrias de biotecnologia e farmácia continuam evoluindo digitalmente de forma acelerada, enquanto forças geopolíticas e econômicas apresentam obstáculos que exigem uma estratégia calibrada ao longo de toda a cadeia de suprimentos. Confira a liderança de ideias do BCG sobre produtos biofármacos para obter informações-chaves sobre o futuro da indústria de ciências da vida.


Featured Insights

Health Care - PLAN for an Effective COVID-19 Response

PLAN for an Effective COVID-19 Response

Preparing Localities for Action Against Novel Coronavirus (PLAN) is a scenario-planning tool that identifies potential US supply and demand imbalances down to the county level.

COVID-19 and the New Leadership Agenda

The COVID-19 outbreak underscores the need to be resilient in the face of transformative global risk.

Winning the ’20s

How should leaders prepare their companies to thrive in the new decade?

Biopharmaceuticals - Getting a Grip on COGS in Generic Drugs

Getting a Grip on COGS in Generic Drugs

BCG’s 2019 benchmark study found that companies need to relentlessly manage the elements that demand the greatest spending—internal and contract manufacturing.

Biotech & Pharmaceuticals in Brazil

Placing Your CAR-T Bets

Placing Your CAR-T Bets

These new therapies are poised to revolutionize oncology. It all depends on reaching a larger patient base and simplifying manufacturing and the supply chain.

Anticipating the Spread of COVID-19 with Scenario Planning

Anticipating the Spread of COVID-19 with Scenario Planning

Accelerating Drug Development Today

How to Lead a Digital Transformation: By Internal Disruption

BCG GAMMA's Transformative Work for an Oncology Center

Using Big Data to Help Fight Cancer

Innovation in Biopharma R&D

Conceitos Básicos de Inovação Externa de um Expert em P&D

Karalee Close on The Digital Opportunity in Healthcare

Frank Cordes on The Pharma Factory of the Future

Mark Lubkeman on A Return to Growth

protected by reCaptcha

Subscribe to our Biopharma eAlert.

Biofarmacêutica